61 related articles for article (PubMed ID: 29207336)
21. Novel Tetrahydro-[1,2,4]triazolo[3,4-
Darwish MIM; Moustafa AM; Youssef AM; Mansour M; Yousef AI; El Omri A; Shawki HH; Mohamed MF; Hassaneen HM; Abdelhamid IA; Oishi H
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110575
[TBL] [Abstract][Full Text] [Related]
22. Novel eco-friendly [1,2,4]triazolo[3,4-a]isoquinoline chalcone derivatives efficiency against fungal deterioration of ancient Egyptian mummy cartonnage, Egypt.
Geweely NS; Soliman MM; Ali RA; Hassaneen HM; Abdelhamid IA
Arch Microbiol; 2023 Jan; 205(2):57. PubMed ID: 36609727
[TBL] [Abstract][Full Text] [Related]
23. [1,2,4] Triazolo [3,4-a]isoquinoline chalcone derivative exhibits anticancer activity via induction of oxidative stress, DNA damage, and apoptosis in Ehrlich solid carcinoma-bearing mice.
WalyEldeen AA; El-Shorbagy HM; Hassaneen HM; Abdelhamid IA; Sabet S; Ibrahim SA
Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1225-1238. PubMed ID: 35881165
[TBL] [Abstract][Full Text] [Related]
24. Insights into the interaction of potent antimicrobial chalcone triazole analogs with human serum albumin: spectroscopy and molecular docking approaches.
Yadav P; Yadav JK; Agarwal A; Awasthi SK
RSC Adv; 2019 Oct; 9(55):31969-31978. PubMed ID: 35530759
[TBL] [Abstract][Full Text] [Related]
25. Chalcones: Synthetic Chemistry Follows Where Nature Leads.
Jasim HA; Nahar L; Jasim MA; Moore SA; Ritchie KJ; Sarker SD
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439870
[TBL] [Abstract][Full Text] [Related]
26. Chalcones as Promising Antitumor Agents by Targeting the p53 Pathway: An Overview and New Insights in Drug-Likeness.
Moreira J; Almeida J; Saraiva L; Cidade H; Pinto M
Molecules; 2021 Jun; 26(12):. PubMed ID: 34205272
[TBL] [Abstract][Full Text] [Related]
27. Bioactive fluorenes. Part III: 2,7-dichloro-9
Hussein EM; Alsantali RI; Morad M; Obaid RJ; Altass HM; Sayqal A; Abourehab MAS; Elkhawaga AA; Aboraia ASM; Ahmed SA
BMC Chem; 2020 Dec; 14(1):42. PubMed ID: 32596690
[TBL] [Abstract][Full Text] [Related]
28. Biological Evaluation and Molecular Dynamics Simulation of Chalcone Derivatives as Epidermal Growth Factor-Tyrosine Kinase Inhibitors.
Sangpheak K; Tabtimmai L; Seetaha S; Rungnim C; Chavasiri W; Wolschann P; Choowongkomon K; Rungrotmongkol T
Molecules; 2019 Mar; 24(6):. PubMed ID: 30897725
[TBL] [Abstract][Full Text] [Related]
29.
Mansour M; Mohamed MF; Elhalwagi A; El-Itriby HA; Shawki HH; Abdelhamid IA
Biomed Res Int; 2019; 2019():2698570. PubMed ID: 30713850
[TBL] [Abstract][Full Text] [Related]
30. Thiazolidinone-linked1,2,3-triazoles with monoterpenic skeleton as new potential anticancer agents: Design, synthesis and molecular docking studies.
Oubella A; El Mansouri AE; Fawzi M; Bimoussa A; Laamari Y; Auhmani A; Morjani H; Robert A; Riahi A; Youssef Ait Itto M
Bioorg Chem; 2021 Oct; 115():105184. PubMed ID: 34333421
[TBL] [Abstract][Full Text] [Related]
31. Anticancer Active Heterocyclic Chalcones: Recent Developments.
Dandawate P; Ahmed K; Padhye S; Ahmad A; Biersack B
Anticancer Agents Med Chem; 2021; 21(5):558-566. PubMed ID: 32628595
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
Mohamed MF; Hassaneen HM; Abdelhamid IA
Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
[TBL] [Abstract][Full Text] [Related]
33. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
34. Novel [l,2,4]triazolo[3,4-a]isoquinoline chalcones as new chemotherapeutic agents: Block IAP tyrosine kinase domain and induce both intrinsic and extrinsic pathways of apoptosis.
Mohamed MF; Sroor FM; Ibrahim NS; Salem GS; El-Sayed HH; Mahmoud MM; Wagdy MM; Ahmed AM; Mahmoud AT; Ibrahim SS; Ismail MM; Eldin SM; Saleh FM; Hassaneen HM; Abdelhamid IA
Invest New Drugs; 2021 Feb; 39(1):98-110. PubMed ID: 32856275
[TBL] [Abstract][Full Text] [Related]
35. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
